Reading the tape
NASDAQ: IRWD
Ironwood Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
$748.44M
52w High
$5.78
52w Low
$0.53
P/E
31.00
Volume
2.72M
Outstanding Shares
163.06M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 394.77%Revenue (TTM): -15.72%FCF (TTM): 22.83%P/FCF: 25th pct
What changed
The stock rose 394.77% over the last year. Revenue declined 15.72% over the trailing twelve months. Operating margin moved from 26.5% to 33.18%. Free cash flow grew 22.83% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 33.18%. A decisive move in revenue — currently down 15.72% — would be the clearest signal to resolve the ambiguity.
Company profile
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
CEOThomas A. McCourt
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees253
IPO dateFeb 3, 2010
Valuation
Forward P/E—
EV/EBITDA8.88
Enterprise value$929.01M
Stock splits
Apr 2, 2019↑ Forward
Every 500 shares became 597
Profitability & growth
Revenue growth-47.31%
Gross margin90.58%▲1.55%vs FY2024
Operating margin33.18%▲51.32%vs FY2024
ROE-9.17%▼3040.93%vs FY2024
Analyst consensus
RatingHold
Target price$4.80▲4.58%
11
Buy
16
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $0.24 · Revenue est $92.11M
View